What is BeOne Medicines Ltd (ONC)?
BeOne Medicines Ltd is a biotechnology company focused on developing novel therapies for cancer and other serious diseases. The company engages in research and development activities aimed at creating targeted treatments based on its proprietary technology platforms. BeOne Medicines collaborates with academic institutions and industry partners to advance its drug candidates through preclinical and clinical stages. Its pipeline includes compounds designed to address unmet medical needs by modulating specific biological pathways. The company operates within the biopharmaceutical sector, which emphasizes innovation, scientific research, and regulatory compliance. BeOne Medicines seeks to contribute to improved patient outcomes through the development of new therapeutic options.
BeOne Medicines Ltd Stock Price Today: Live Overview
The price today is shaped by active session trading, with DigitalX Limited trading at $276.05. The intraday movement ranges from $270.25 to $276.51, reflecting a daily change of +0.2659%.
FAQ: BeOne Medicines Ltd (ONC)
What is the current price of ONC stock?
BeOne Medicines Ltd's current price is $276.05.
Does ONC pay dividends?
The company does not pay dividends.
Does ONC have a formal corporate presence or regional headquarters in the UAE?
BeOne Medicines Ltd operates in the UAE exclusively through partners and distributors without a direct office or subsidiary.
What is ONC best known for?
The company is most famous for its work in developing novel therapeutics for cancer treatment.
What assets are typically shown together with ONC?
Commonly shown alongside ONC: EMQQ Emerging Markets Internet UCITS ETF, Kier Group, Capital City Bank
Latest shares articles



